In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss. Latest U.S.

A new oral anti-diabetes pill, orforglipron, shows similar effectiveness to injectable GLP-1 drugs in a Phase 3 trial.

Eli Lilly’s experimental pill for weight loss helped people lose an average of 15% of their body weight after 36 weeks on the highest dose in a midstage trial, rivaling what’s seen with ...

How effective is Eli Lilly’s new weight loss pill compared to ... Secretary Robert F. Kennedy Jr. Kennedy has been a critic of GLP-1 drugs, saying people should simply eat a healthier diet. ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 diabetes lose an average of nearly 8% of their body weight after 40 weeks ...

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, ... but also the processed food and diet industries that have fueled and capitalized on the obesity ...

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type 2 diabetes. Previous versions were administered via injection.

Eli Lilly and Company, which already markets weight-loss and diabetes drugs that must be injected, is a step closer to introducing a once-daily pill for the same conditions.

But Eli Lilly says they didn’t see any signs of liver injury in the trial, unlike what happened with Pfizer’s pill. As for the only GLP-1 pill on the market, it’s called Rybelsus.

Lilly pill cuts genetic form of cholesterol nearly 86% in study. By Julie Steenhuysen. November 19, ... the so-called bad cholesterol that can be treated with diet and statins, ...